Resolution of Left Bundle Branch Block Due To Treatment of COVID-19-Related Myocarditis
1University of Istanbul, Institute of Cardiology, Department of Cardiology, Istanbul, Turkey
2Istanbul Kartal Dr. Lutfi Kirdar Training and Research Hospital, Department of Cardiology, Istanbul, Turkey
Keywords: Left bundle branch block, COVID-19, myocarditis
We present the case of a 67-year-old woman with novel coronavirus-infected pneumonia, who was subsequently diagnosed with coronavirus disease 2019 (COVID-19)-related myocarditis and left bundle branch block (LBBB). COVID-19-infected pneumonia treatment, such as oseltamivir, azithromycin, ceftriaxone, and ascorbic acid, may be related to the reduction of myocarditis lesion. Reduction in lesions’ size may improve the conduction system; therefore, LBBB can also be resolved in the treatment of COVID-19-infected pneumonia.
Written informed consent was obtained from the patient who participated in this study.
Concept/Design - MY; Analysis/Interpretation - BY, EP, SY; Writing - MY; Critical Revision - MY, BY; Final Approval - MY.
The authors have no conflict of interest to declare.
The authors declared that this study has received no financial support.